Gene Query: RAB40C

Dataset Description Geneva Score
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 46.79
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 43.42
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 19.29
Energy Metabolism during Anchorage-Independence 16.49
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 15.77
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 14.95
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 14.09
Gene expression analysis in response to hypoxic pathway inhibition 10.82
H1609088 Human RNA-Sequencing 9.85
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 9.8
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 9.24
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 9.24
MOF acetyl transferase regulates transcription and respiration in mitochondria 8.14
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 8.02
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 8.02
Paxillin regulates genomic networks in prostate cancer [LNCaP] 7.83
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 7.27
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.2
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.2
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.13
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.13
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 7.08
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 6.68
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 6.53
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 6.36
Gene expression in GBM with Cav3.2 inhibition 6.25
RNAseq of IL-36 stimulated primary human keratinocytes 6.23
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 6.0
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 6.0
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 5.81
Active translatome profiling with RiboLace in MCF7 cells 5.54
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.53
Silencing p300 in MCF7 cells to study expression and alternative splicing 5.37
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.22
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.2
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 5.19
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 5.14
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.14
RNA sequencing of GlyH-101-treated MCF-7 cell line 5.14
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 5.06
CHCHD10 gene KO effect in iPSC drived motor neurons 5.04
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 5.02
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 5.02
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 4.99
Differetially expressed genes after hTR overexpression in U2OS cells 4.92
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 4.81
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 4.81
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 4.81
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 4.63
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 4.53
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 4.52
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 4.52
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 4.4
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 4.4
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 4.31
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 4.18
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 4.18
CHCHD2 gene KO effect in iPSC drived motor neurons 4.16
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.09
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.07
Glioblastoma stem cells infected by ZIKA virus 4.07
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.93
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 3.88
Non-coding regions are the main source of tumor-specific antigens [human] 3.87
Non-coding regions are the main source of tumor-specific antigens 3.87
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.76
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 3.74
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 3.68
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.65
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 3.6
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.58
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.58
Transciptomic profiling of human fetal lung samples 3.58
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.5
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 3.42
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 3.42
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.37
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 3.36
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.35
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 3.34
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 3.32
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.3
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 3.28
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.27
The evolution of N6-methyladenosine in primates 3.27
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 3.23
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.22
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 3.22
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 3.22
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.21
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.21
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 3.19
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.17
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 3.12
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.12
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.12
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 3.11
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 3.03
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.0
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.99
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.98
RNA-seq analysis of AML cells in response to ASLAN003 2.98
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.97
RNA-Seq of PRMT1 overexpression ECA109 cells 2.97
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.96
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.95
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.95
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 2.89
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.86
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.85
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 2.85
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 2.82
Genome wide expression change in LCC2 and MCF-7 cells 2.76
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.74
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.74
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 2.71
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 2.71
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.7
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 2.68
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 2.68
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.66
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.66
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.65
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 2.64
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.63
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.56
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.54
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.53
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.52
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.49
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.49
Effect of CHKA knockdown on C4-2 cell transcriptome 2.48
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.48
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.48
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.47
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.47
RNAseq Analysis in glioblastoma cells treated with Mepazine 2.47
circRNA-sequencing 2.45
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 2.44
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.42
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.42
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 2.42
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 2.42
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 2.41
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.41
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.38
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.37
Global epigenomic reconfiguration during mammalian brain development 2.36
The transcriptome effect of overexpressing EZH2 in MCF7 2.36
Transcriptome Profiling of Human Primary Monocytes 2.35
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 2.35
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 2.35
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.34
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.34
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.32
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.29
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.29
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 2.28
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.27
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 2.26
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 2.26
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 2.24
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.24
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.24
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 2.23
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.23
RNA-seq of shEZH2 cells 2.23
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.23
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 2.22
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.2
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.19
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.19
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 2.19
Transcriptome analysis of SKI knock-out in HL60 cells 2.18
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.18
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.18
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 2.16
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 2.16
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.16
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 2.15
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 2.15
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 2.15
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.15
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.15
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 2.14
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 2.13
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.12
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.12
LNCaP treated with iBET 2.11
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 2.09
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 2.09
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.09
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 2.08
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 2.08
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.08
T47D RNA-seq and ChrRNA-seq data 2.08
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 2.05
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.05
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.03
Accurate annotation of human protein-coding small open reading frames 2.02
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.01
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.01
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 2.01
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.01
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 2.0
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.0
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 1.99
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.99
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.99
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.98
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.98
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.96
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 1.95
Regulation of highly expressed hCINAP on translatome 1.95
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  1.95
RNA transcriptome analysis during HSV-1 infection 1.95
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.94
Gene expression in PANC1 cells treated with Rakicidin 1.94
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.94
Global analysis of alternative splicing regulated by RBM10 1.94
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.92
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.89
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.89
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.87
RNA-Seq and expression data from human adipose tissue 1.87
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 1.87
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 1.87
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.87
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.87
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.87
High-throughput sequencing of pluripotent cells 1.87
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.87
RNA-seq of YB5 cells treated with Proscillaridin A 1.86
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 1.86
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 1.85
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 1.85
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 1.84
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.83
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 1.83
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 1.83
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 1.83
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.83
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 1.82
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.81
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 1.81
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.8
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 1.8
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 1.8
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.79
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 1.76
snRNAs as regulators of alternative splicing 1.75
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.75
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.75
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 1.74
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 1.73
Targeting MTHFD2 in Acute Myeloid Leukemia 1.71
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 1.69
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 1.68
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.67
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.65
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.64
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 1.63
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.62
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 1.62
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 1.62
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 1.61
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.61
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.58
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 1.58
Identification of HOXB13 target genes responsive to BET inhibitors 1.57
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.56
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.56
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.55
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.55
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 1.53
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 1.52
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.5
RNA-seq analysis of the human fetal kidney. 1.5
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.49
Transcriptomic analysis of the HOTAIR-regulated genes 1.48
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.48
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.47
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.46
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.45
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.45
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.45
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.45
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.45
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 1.42
Interaction between mitoNEET and NAF-1 in cancer cells 1.41
U2AF1 mutations alter splice site recognition in hematological malignancies 1.41
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.4
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.39
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.38
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.38
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.37
Genome-wide functional assessment of enhancer activities in the human genome 1.36
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 1.35
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 1.35
Patient-derived luminal breast cancer xenografts with progestins 1.35
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.35
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.35
SUV420H2 knockdown in PANC-1 1.34
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.33
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.33
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.32
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 1.31
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.31
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 1.29
A transcriptome-wide divergence in protein translation scales with LIN28B expression 1.29
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.28
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.28
Gene expression analysis upon mtDNA depletion 1.28
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.26
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.25
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.25
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.23
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 1.22
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.22
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.21
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.19
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.19
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 1.18
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.16
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 1.15
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 1.15
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.13
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 1.13
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.13
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.12
Genome-wide discovery of human splicing branchpoints 1.09
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.08
RNA sequencing of human pancreatic cancer cell lines 1.08
Identification of long noncoding RNAs in T-ALL cell lines 1.03
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.01
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.0
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.0
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.0
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.0
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.0
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 0.99
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.99
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.98
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.98
RNAseq of cell lines with knocked in ESR1 mutations 0.97
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 0.97
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.97
Genome-wide discovery of human splicing branchpoints [RNAse] 0.96
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 0.95
RNA-seq analysis upon ARID1B overexpression 0.92
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.92
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.9
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.9
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.89
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.89
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.87
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 0.86
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 0.86
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.85
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 0.83
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.83
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.82
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 0.82
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.82
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.81
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.8
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.79
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.78
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.78
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.78
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.77
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.76
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.76
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.76
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.76
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.75
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 0.74
quanTIseq: quantifying immune contexture of human tumors 0.73
RNA Seq of Alagille liver biopsies 0.73
Alagille_Nodder 0.73
Fusion discovery in breast cancer cell line 0.73
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 0.71
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.7
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.69
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.67
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.67
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.66
Gene expression analysis of human adenomas. 0.65
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.65
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.65
Functional significance of the HIV-1 Tat signature amino acid residues 0.65
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.65
Gene expression analysis of breast cancer cell-lines 0.64
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.64
Androgen Receptor-regulated genes in prostate cancer cells 0.63
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.63
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.63
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.62
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.57
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.57
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.57
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.56
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.56
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.56
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.55
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.53
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.53
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.52
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.52
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.52
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.52
Oncogenic roles of ARID5B in T-ALL 0.51
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.51
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.51
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.51
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.51
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.48
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.48
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.48
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.47
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.47
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 0.47
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.46
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.46
Noncoding regions are the main source of targetable tumor-specific antigens 0.46
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.45
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.45
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.45
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.44
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.44
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.43
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.43
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.41
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.39
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.38
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.38
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.37
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.37
The role of the Calcium-Sensing receptor in colorectal cancer 0.35
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.34
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 0.34
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 0.34
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.33
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.33
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 0.33
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.33
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.33
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.32
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.32
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.32
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.3
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.3
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.3
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.28
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.28
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.27
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.26
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.25
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.25
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.24
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.24
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.21
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.2
The transcriptome and chromatin accessbility landscape of mammalian germline 0.19
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 0.19
Molecular analysis of renal cell carcinoma with unclassfied histology 0.19
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.19
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.19
PTHrP overexpression in MCF7 cells 0.18
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.17
miRNAs affected by antagomiR-17 treatment 0.16
KSDM1b Role in Ewing Sarcoma 0.16
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.15
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.15
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.15
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.12
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.12
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.11
The role of m6A/m-RNA methylation in stress response regulation 0.11
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.09
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.09
Preclinical model of obesity and ER-positive breast cancer 0.09
Direct Isolation and Characterization of Human Nephron Progenitors. 0.08
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.07
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.07
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.07
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.05
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.05
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.05
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.04
Comparative Analysis of Cas9 Activators Across Multiple Species 0.03
Leucegene: AML sequencing (part 6) 0.03
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.03
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.03
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.03
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.03
The MEF2B Regulatory Network - RNA-seq data 0.02
The MEF2B Regulatory Network 0.02
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.02
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation